• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Schrodinger Inc (NQ: SDGR )

    17.99 +0.40 (+2.27%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Schrodinger Inc

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Schrödinger Reports Second Quarter 2023 Financial Results
    From Schrödinger, Inc.
    Via Business Wire
    Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
    Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
    A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Exscientia is the Sniper of the AI Drug Discovery Industry
    News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
    Via Benzinga
    3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
    They're not guaranteed to keep soaring, but they are right now. 
    Via The Motley Fool
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger, Inc.
    Via Business Wire
    Schrödinger to Announce Second Quarter 2023 Financial Results on August 2
    From Schrödinger, Inc.
    Via Business Wire
    Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals
    Both companies could tap into huge growth from the AI revolution in a few years. 
    Via The Motley Fool
    This Artificial Intelligence Biotech Stock Is Crushing the Market, but Is It a Buy?
    Its software platform could become a core tool for many businesses in biopharma. 
    Via The Motley Fool
    Nvidia Invested $50 million into This AI Drug Discovery Biotech
    Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood's Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm
    Via Benzinga
    Stocks Pulsate As June Inflation Undercuts Expectations: 10 Major Reactions
    Via Benzinga
    Trump Advisor Says Ex-President May Skip Initial Republican Presidential Primary Debates
    Via Benzinga
    Why These 3 Stocks Are the Best Ways to Play AI Right Now
    These three AI stocks are growing rapidly, and their stock prices are a very long way from reflecting their true, tremendous potential. 
    Via InvestorPlace
    The 3 Best Sectors to Invest in for July 2023
    The best sectors for investors are those getting boosts from two strong trends: the electrification of transportation and AI. 
    Via InvestorPlace
    Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
    Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market... 
    Via Benzinga
    ETF Returns: Mid-Cap Winners And Losers
    We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on... 
    Via Benzinga
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger, Inc.
    Via Business Wire
    7 Stocks in Hot Water: Dump This Dead Weight as Costs Skyrocket
    While an uncomfortable topic that arouses a range of emotions, investors must grapple with overvalued stocks to sell. 
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    3 AI Stocks That Could Skyrocket Your Wealth
    AI is poised to greatly increase the top and bottom lines of many companies, making many AI stocks very attractive at this point. 
    Via InvestorPlace
    Why Shares of Schrödinger Rose This Week
    Interest in the company's AI platform continues to drive the stock. 
    Via The Motley Fool
    Gambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    3 Revolutionary Companies With Trillion-Dollar Potential
    These are just a few of the trillion-dollar potential companies to put on your radar screen for the second half. 
    Via InvestorPlace
    Palo Alto Networks Shares Surge As It Joins S&amp;P 500: Who Is It Replacing?
    Via Benzinga
    Palo Alto Networks To Join S&P 500 Index: Here Are All The S&P Index Changes
    Here are the changes to the S&P indexes before the open on June 20. 
    Via Investor's Business Daily
    Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference
    From Schrödinger
    Via Business Wire
    3 Pharma Stocks That Will Boom Thanks to AI
    Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms. 
    Via InvestorPlace
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.